Business Description
Double Bond Pharmaceutical International AB
ISIN : SE0007185525
Description
Financial Strength
7/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | No Debt | |||||
Equity-to-Asset | 0.73 | |||||
Piotroski F-Score | 5/9 | |||||
Altman Z-Score | 2.2 | |||||
Beneish M-Score | -14.86 | |||||
WACC vs ROIC |
Growth Rank
9/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | -14 | |||||
3-Year EBITDA Growth Rate | 18.9 | |||||
3-Year EPS without NRI Growth Rate | 25.1 | |||||
3-Year Book Growth Rate | -44.6 | |||||
Future 3-5Y Total Revenue Growth Rate | 27.9 |
Momentum Rank
5/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 24.87 | |||||
9-Day RSI | 31.92 | |||||
14-Day RSI | 35.35 | |||||
6-1 Month Momentum % | -31.13 | |||||
12-1 Month Momentum % | 27.55 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 1.13 | |||||
Quick Ratio | 1.13 | |||||
Cash Ratio | 0.6 | |||||
Days Sales Outstanding | 15.41 | |||||
Days Payable | 36.71 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -22.1 |
Profitability Rank
2/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | -110.72 | |||||
Operating Margin % | -787.06 | |||||
Net Margin % | -1077.15 | |||||
FCF Margin % | 839.68 | |||||
ROE % | -163.86 | |||||
ROA % | -118.49 | |||||
ROIC % | -104.05 | |||||
ROC (Joel Greenblatt) % | -8394.71 | |||||
ROCE % | -161.57 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PS Ratio | 25.94 | |||||
PB Ratio | 6.48 | |||||
Price-to-Tangible-Book | 6.92 | |||||
Price-to-Free-Cash-Flow | 3.17 | |||||
Price-to-Operating-Cash-Flow | 3.17 | |||||
EV-to-EBIT | -2.58 | |||||
EV-to-Forward-EBIT | -3.3 | |||||
EV-to-EBITDA | -2.6 | |||||
EV-to-Revenue | 27.39 | |||||
EV-to-Forward-Revenue | 23.01 | |||||
EV-to-FCF | 3.46 | |||||
Earnings Yield (Greenblatt) % | -38.82 | |||||
FCF Yield % | 29.59 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
Double Bond Pharmaceutical International AB Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil kr) | 1.492 | ||
EPS (TTM) (kr) | -0.164 | ||
Beta | 1.82 | ||
Volatility % | 125.99 | ||
14-Day RSI | 35.35 | ||
14-Day ATR (kr) | 0.067592 | ||
20-Day SMA (kr) | 0.47525 | ||
12-1 Month Momentum % | 27.55 | ||
52-Week Range (kr) | 0.251 - 1.995 | ||
Shares Outstanding (Mil) | 102.03 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 5 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Double Bond Pharmaceutical International AB Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Double Bond Pharmaceutical International AB Stock Events
Event | Date | Price(kr) | ||
---|---|---|---|---|
No Event Data |
Double Bond Pharmaceutical International AB Frequently Asked Questions
What is Double Bond Pharmaceutical International AB(XSAT:DBP B)'s stock price today?
When is next earnings date of Double Bond Pharmaceutical International AB(XSAT:DBP B)?
Does Double Bond Pharmaceutical International AB(XSAT:DBP B) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |